Cambridge Cancer Genomics

Cambridge Cancer Genomics Overview

  • Founded
  • 2017
Founded
  • Status
  • Private
  • Employees
  • 25
Employees
  • Latest Deal Type
  • Accelerator/​Inc
  • Investors
  • 15

Cambridge Cancer Genomics General Information

Description

Developer of a medical test platform designed to track the response of cancer therapy. The company's medical test platform is a point of care of diagnostic device which monitors the proportion of circulating tumor DNA in a patient's blood sample to determine how a patient is responding to therapy, enabling clinicians to monitor treatment response in near real time, leading to rapid decision making on choice of therapy, improve patient quality of life and increase survival rates.

Contact Information

Website
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Monitoring Equipment
Other Industries
Diagnostic Equipment
Biotechnology
Primary Office
  • 72 Hills Road
  • Cambridge CB2 1LA
  • England, United Kingdom

Cambridge Cancer Genomics Timeline

201820192020
Date FoundedFinancing RoundCaptured Employee CountEstimated Employee Growth
Want detailed data on 2M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Cambridge Cancer Genomics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
7. Accelerator/Incubator 30-Jan-2020 00.000 Completed Generating Revenue
6. Seed Round 18-Dec-2018 00.00 00.000 Completed Startup
5. Early Stage VC 01-Nov-2017 00.000 00.000 Completed Startup
4. Early Stage VC 22-Aug-2017 00.00 00.000 Completed Startup
3. Accelerator/Incubator 21-Aug-2017 00000 00000 00.000 Completed Startup
2. Early Stage VC 01-Aug-2017 Completed Startup
1. Accelerator/Incubator Completed Startup

Cambridge Cancer Genomics Executive Team (6)

Name Title Board Seat Contact Info
John Cassidy Ph.D Co-Founder, Chief Executive Officer & Board Member
Harry Clifford Co-Founder & Chief Technology Officer
Nirmesh Patel Ph.D Co-Founder & Chief Scientific Officer
Emil Hewage Ph.D Founding Advisor

2 Former Executives

Cambridge Cancer Genomics Board Members (1)

Name Representing Role Since
John Cassidy Ph.D Cambridge Cancer Genomics Co-Founder, Chief Executive Officer & Board Member 000 0000

Cambridge Cancer Genomics Investors (15)

To view Cambridge Cancer Genomics‘s full investor history, request access »
Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Merck Innovation Center Accelerator/Incubator Minority 000 0000 000000 0
AME Cloud Ventures Venture Capital Minority 000 0000 000000 0
Romulus Capital Venture Capital Minority 000 0000 000000 0
Amplify Partners Venture Capital Minority 000 0000 000000 0
Endure Capital Venture Capital Minority 000 0000 000000 0

Ready to get started?

Request a free trial